Expertise in
8
conditions

Dr. Amir Kamran

Hematology
CAMC Cancer Center
3415 Maccorkle Ave SE, 
Charleston, WV 
Clinical Trials:Currently Recruiting for 2 Trials
Expertise in
8
conditions
CAMC Cancer Center
3415 Maccorkle Ave SE, 
Charleston, WV 

Overview

Amir Kamran is a Hematologist in Charleston, West Virginia. Dr. Kamran is highly rated in 8 conditions, according to our data. His top areas of expertise are Prostate Cancer, Muscle Invasive Bladder Cancer, Renal Cell Carcinoma (RCC), and Chromophobe Renal Cell Carcinoma.

His clinical research consists of co-authoring 24 peer reviewed articles and participating in 5 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties

Hematology

Licenses

Internal Medicine in WV

Hospital Affiliations

Charleston Area Medical Center
Boone Memorial Hospital

Languages Spoken

English

Gender

Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem BCBS
  • EPO
  • HMO
  • POS
  • PPO
CareSource
  • HMO
Cigna
  • EPO
  • HMO
  • PPO
Dominion National
  • MEDICARE PDP
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicaid
  • OTHER MEDICAID
  • STATE MEDICAID
Premera Blue Cross
  • INSURANCE PLAN
  • MEDICARE MAPD
  • OTHER COMMERCIAL
  • PPO
The Health Plan
  • HMO
  • MANAGED MEDICAID PLAN
  • OTHER MEDICARE PART D
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 9 Less Insurance Carriers -

Locations

CAMC Cancer Center
3415 Maccorkle Ave SE, Charleston, WV 25304

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

5 Clinical Trials

Establishment of a National Biorepository to Advance Studies of Immune-Related Adverse Events
Establishment of a National Biorepository to Advance Studies of Immune-Related Adverse Events
Enrollment Status: Recruiting
Publish Date: February 04, 2026
Intervention Type: Procedure, Other
Phase III Randomized Trial of Standard Systemic Therapy (SST) Versus Standard Systemic Therapy Plus Definitive Treatment (Surgery or Radiation) of the Primary Tumor in Metastatic Prostate Cancer
Phase III Randomized Trial of Standard Systemic Therapy (SST) Versus Standard Systemic Therapy Plus Definitive Treatment (Surgery or Radiation) of the Primary Tumor in Metastatic Prostate Cancer
Enrollment Status: Recruiting
Publish Date: September 11, 2025
Intervention Type: Procedure, Drug, Other, Radiation
Study Drugs: Abiraterone, Bicalutamide, Degarelix, Docetaxel, Flutamide, Goserelin acetate, Histrelin acetate, Leuprolide acetate, Nilutamide, Prednisone, Triptorelin
Study Phase: Phase 3
Phase III Randomized Adjuvant Study of Pembrolizumab in muScle invaSive and locAlly aDvanced urOthelial caRcinoma (AMBASSADOR) Versus Observation
Phase III Randomized Adjuvant Study of Pembrolizumab in muScle invaSive and locAlly aDvanced urOthelial caRcinoma (AMBASSADOR) Versus Observation
Enrollment Status: Active_not_recruiting
Publish Date: February 12, 2026
Intervention Type: Other, Biological, Procedure
Study Drug: Pembrolizumab
Study Phase: Phase 3
PD-Inhibitor (Nivolumab) and Ipilimumab Followed by Nivolumab Vs. VEGF TKI Cabozantinib With Nivolumab: A Phase III Trial in Metastatic Untreated REnal Cell CancEr [PDIGREE]
PD-Inhibitor (Nivolumab) and Ipilimumab Followed by Nivolumab Vs. VEGF TKI Cabozantinib With Nivolumab: A Phase III Trial in Metastatic Untreated REnal Cell CancEr [PDIGREE]
Enrollment Status: Active_not_recruiting
Publish Date: November 17, 2025
Intervention Type: Other, Procedure, Drug, Biological
Study Drugs: Cabozantinib, Ipilimumab, Nivolumab
Study Phase: Phase 3
Randomized Phase II Trial of Niraparib With Standard Combination Radiotherapy and Androgen Deprivation Therapy (ADT) in High Risk Prostate Cancer (With Initial Phase I) (NADIR*) *Randomized Phase II Trial of Niraparib With Standard Combination Androgen DeprIvation Therapy (ADT) and Radiotherapy in High Risk Prostate Cancer (With Initial Phase I)
Randomized Phase II Trial of Niraparib With Standard Combination Radiotherapy and Androgen Deprivation Therapy (ADT) in High Risk Prostate Cancer (With Initial Phase I) (NADIR*) *Randomized Phase II Trial of Niraparib With Standard Combination Androgen DeprIvation Therapy (ADT) and Radiotherapy in High Risk Prostate Cancer (With Initial Phase I)
Enrollment Status: Active_not_recruiting
Publish Date: July 28, 2025
Intervention Type: Biological, Drug, Radiation
Study Drugs: Gonadotrophin releasing hormone, Niraparib
Study Phase: Phase 1/Phase 2
View 3 Less Clinical Trials

24 Total Publications

The impact of neutropenia severity in the setting of recent chemotherapy on mortality in sepsis.
The impact of neutropenia severity in the setting of recent chemotherapy on mortality in sepsis.
Journal: International journal of clinical oncology
Published: September 15, 2025
Similar Doctors
Expertise in
55
conditions
Dr. Narender Jogenpally
Hematology
Expertise in
55
conditions
Dr. Narender Jogenpally
Hematology

Arvind B Shah MD Inc

401 Division St Ste 100, 
South Charleston, WV 
 (8.2 miles away)
304-766-4350
Languages Spoken:
English
See accepted insurances

Narender Jogenpally is a Hematologist in South Charleston, West Virginia. Dr. Jogenpally is highly rated in 55 conditions, according to our data. His top areas of expertise are Familial Colorectal Cancer, Inflammatory Breast Cancer, Colorectal Cancer, Angiosarcoma, and Bone Marrow Aspiration.

Expertise in
24
conditions
Dr. John Ponugupati
Hematology
Expertise in
24
conditions
Dr. John Ponugupati
Hematology

Arvind B Shah MD Inc

401 Division St Ste 100, 
South Charleston, WV 
 (8.2 miles away)
304-766-4350
Languages Spoken:
English
See accepted insurances
Offers Telehealth

John Ponugupati is a Hematologist in South Charleston, West Virginia. Dr. Ponugupati is highly rated in 24 conditions, according to our data. His top areas of expertise are Childhood Iron Deficiency Anemia, Colorectal Cancer, Familial Colorectal Cancer, Iron Deficiency Anemia, and Bone Marrow Aspiration.

Expertise in
56
conditions
Dr. Arvinder Bir
Hematology
Expertise in
56
conditions
Dr. Arvinder Bir
Hematology

Ultimate Health Services Inc.

3075 US Route 60, 
Huntington, WV 
 (41.5 miles away)
304-528-4600
Languages Spoken:
English
See accepted insurances

Arvinder Bir is a Hematologist in Huntington, West Virginia. Dr. Bir is highly rated in 56 conditions, according to our data. His top areas of expertise are Paget Disease of the Breast, Angiosarcoma, Inflammatory Breast Cancer, and Pleuropulmonary Blastoma.

Frequently Asked Questions about Dr. Amir Kamran

How do I make an appointment with Dr. Amir Kamran?

You can book an appointment with Dr. Amir Kamran by calling their office at 304-388-8380. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.

Is Dr. Amir Kamran a top-rated expert for Prostate Cancer?

MediFind is an objective health platform that identifies experts based on real-world data. Dr. Amir Kamran is classified as an Advanced expert for Prostate Cancer, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

What conditions does Dr. Amir Kamran specialize in?

While Dr. Amir Kamran is a Hematology, they have specific expertise in Prostate Cancer, Muscle Invasive Bladder Cancer, and Renal Cell Carcinoma (RCC). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Hematology.

Does Dr. Amir Kamran participate in research or clinical trials?

Yes. Dr. Amir Kamran has published 24 articles and abstracts on conditions like Prostate Cancer. You can view a list of Dr. Amir Kamran's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Does Dr. Amir Kamran accept my insurance?

Dr. Amir Kamran accepts most major insurance plans, including Aetna and Anthem BCBS. We recommend calling the office directly at 304-388-8380 to verify that your specific plan is currently accepted before your visit.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Kamran's expertise for a condition
ConditionClose
      View All 8 Advanced Conditions
      View All 53 Experienced Conditions
      Want to save this doctor for later?
      Sign Up
      Is this your doctor?
      Find A Second Opinion
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile